Clinical Trials Logo

Brain Injuries, Traumatic clinical trials

View clinical trials related to Brain Injuries, Traumatic.

Filter by:

NCT ID: NCT01952288 Completed - Clinical trials for TBI-Traumatic Brain Injury

Simvastatin for mTBI

Start date: September 16, 2013
Phase: Phase 4
Study type: Interventional

Study of simvastatin in Iraq/Afghanistan Veterans with multiple blast exposure and mTBI. The study will measure substances in cerebrospinal fluid (CSF) that are related to dementing disorders.

NCT ID: NCT01948947 Completed - Clinical trials for TBI (Traumatic Brain Injury)

Improving Functions in MTBI Patients With Headache by rTMS

Start date: May 2014
Phase: N/A
Study type: Interventional

Due to recent wars in Afghanistan and Iraq, the number of Veteran suffering from Mild traumatic brain(MTBI) injury and PTSD increases rapidly. Headache is one of the most debilitating clinical symptoms in Veteran with MTBI and the cause of it is still not entirely clear. Recently, the use of non-invasive brain stimulation such as repetitive transcranial magnetic stimulation(rTMS) has yielded favorable clinical outcome in a few intractable chronic central pain conditions including headaches. This study aims to 1) assess the effect of rTMS in relieving headache and improving neurophysiological functions; and 2)explore the neuronal mechanisms associated with MTBI related headache and the analgesic effect of rTMS with function magnetic resonance imaging (fMRI).

NCT ID: NCT01948505 Completed - Clinical trials for Endovascular Patients Undergoing Intracranial Intervention

Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit

Start date: August 2013
Phase: Phase 4
Study type: Interventional

To assess the efficacy of an intravenous nonnarcotic pain medication on controlling patient pain. To assess the effect of an intravenous nonnarcotic pain medication on patient sedation levels in neurocritically ill patients. To assess the effect of an intravenous nonnarcotic pain medication on common side effects seen in patients taking other intravenous narcotic pain medication in the neurocritical care unit.

NCT ID: NCT01947504 Completed - Clinical trials for Mild Traumatic Brain Injury

Early Intervention Following Mild TBI

Start date: January 2016
Phase: N/A
Study type: Interventional

The objective of the study is to implement and measure the efficiency of a standardized acute and brief non-pharmacological intervention (Cognitive interventions on Sleep - Anxiety - Attention - Memory) following mild TBI and observe their impact pre- and post-treatments. The ultimate goal is to have patients be re-integrated to their activities faster with lesser symptoms and have patients present lesser post-concussive symptoms. Specific objectives: 1) Measure the effect of an acute and brief non-pharmacological intervention on PCS symptoms, sleep, headaches, affect, cognition and functional outcome following mild TBI; 2)To redefine a model of outcome prediction following mild TBI.

NCT ID: NCT01935609 Completed - Clinical trials for Traumatic Brain Injury

Evaluation of a Skill-Building, Supportive, and Educational Intervention for Couples

Start date: March 2013
Phase: N/A
Study type: Interventional

1. To evaluate the efficacy of a structured outpatient couples intervention program (Therapeutic Couples Intervention, TCI) on couples' marital quality after acquired brain injury (ABI). 2. To assess the impact of the TCI on the emotional well-being of persons with ABI and their partners. 3. To ascertain the impact of the TCI on caregiver burden and unmet needs as reported by partners of persons with ABI. 4. To examine the extent to which treatment benefits for survivors and their caregiving partners are sustained in the longer-term.

NCT ID: NCT01933217 Completed - Clinical trials for Traumatic Brain Injury

Methylphenidate for Attention Problems After Pediatric TBI

Start date: November 2013
Phase: Phase 4
Study type: Interventional

Traumatic Brain Injury (TBI) - methylphenidate treatment

NCT ID: NCT01925963 Completed - Clinical trials for Focus: Healthy Adults Without Brain Injury

Normative Datasets for Assessments Planned for Mild Traumatic Brain Injury (NORMAL)

NORMAL
Start date: January 10, 2014
Phase:
Study type: Observational

The purpose of the research study is to collect information about brain function and structure among active duty military personnel or civilians who are healthy. Researchers want to develop a database from normal volunteers that will be used in comparison with a similar database from active duty military with post-concussive syndrome (PCS) from a mild traumatic brain injury. Findings from this study may be used to design larger studies that will evaluate whether hyperbaric oxygen treatments actually improve PCS. Participants in this study will undergo numerous tests to assess physical, mental, and intellectual health and how they might change over time. Participants will wear heart and activity monitors, undergo brain imaging, provide blood and urine for laboratory testing, and have vision, hearing, balance, and muscle function tests. They will also complete a number of questionnaires and interviews. This battery of tests will be repeated twice more over the course of 6 months.

NCT ID: NCT01921179 Completed - Clinical trials for Post Traumatic Stress Disorder

Rehabilitation of Executive Functioning in Veterans With PTSD and Mild TBI

Start date: July 31, 2013
Phase: N/A
Study type: Interventional

One of the most pressing concerns within the VA currently is the provision of interventions that address the cognitive as well as emotional problems faced by Veterans with concurrent mild TBI and PTSD. One purpose of this study is to learn more about how PTSD and mild brain injury influences how people think, act, and feel. This may include how people pay attention, keep information in memory, organize plans for achieving important goals, and manage stress. Another purpose of this research is to learn more about the effects of cognitive training on the thinking, behavior, and emotions of individuals with PTSD and mild brain injury - both in the short- and long-term. With this research, the investigators hope to better understand and treat cognitive and emotional difficulties that can occur due to PTSD and mild brain injury.

NCT ID: NCT01903525 Completed - Clinical trials for Mild Traumatic Brain Injury

DHA For The Treatment of Pediatric Concussion Related to Sports Injury

Start date: September 2013
Phase: Phase 1
Study type: Interventional

In recent years, media attention has focused on the long-term sequelae of repeated concussive episodes in professional athletes. The growing understanding of the damage done by what was once considered a "ding" during a game or match, and the neurologic consequences of "playing through" or returning to play too soon has led to additional interest in and concern for pediatric athletes (18 or under) who experience sports-related concussions during game or practice play. Because it has only been in recent years that the full scope of damage done by repeated concussive episodes has come to light, very little research has been done on treatment of concussion in either adults or children. Brain injuries in children can be especially problematic, as the brain may continue to develop until the child reaches the age of 24 or older, so concussion during this time of development may be particularly damaging. Docosahexaenoic acid (DHA) is an omega-3 fatty acid commonly found in both fish oils and algae. DHA is known to improve development of the eyes and brain in young children. It is thought to be an effective anti-inflammatory and anti-oxidant, and since it occurs naturally and causes very few harmful side effects, it may be a useful compound in the treatment of pediatric concussion. This is a feasibility trial of DHA for the treatment of sports concussion in a pediatric population. The investigators' primary aim is to determine acceptability of randomization for this compound as well as rate of enrollment given our clinical population. The investigators' secondary aim is to examine preliminary outcomes. The investigators hypothesize that subjects who take 2 g of DHA daily for 3 months will see a shorter time to full recovery and return to play and a shorter time to resolve balance disturbance. These are good, albeit unvalidated, clinical indicators of concussive recovery.

NCT ID: NCT01886222 Completed - Brain Injuries Clinical Trials

Randomized Controlled Trial of Long-term Mild Hypothermia for Severe Traumatic Brain Injury

LTH-?
Start date: November 12, 2013
Phase: N/A
Study type: Interventional

This study is a prospective multi-centre randomized trial to compare the effect of long-term mild hypothermia versus routine normothermic intensive management in patients with severe traumatic brain injury. The primary hypothesis is that the induction of mild hypothermia (maintained at 34-35℃) for 5 days will improve the outcome of patients at six months post injury compared with normothermia.